We have disciplined operators running lean businesses in a crowded landscape. Rescheduling won’t mean a windfall — it will ...
Moving cannabis to a category of drugs that includes some common medicines will have implications for research, businesses ...
Decades of research show syringe programs are extremely effective at preventing infectious disease among intravenous drug ...
Once cannabis has hijacked the reward center, daily users have no destination in mind. Here's how parents maintain empathy for an addicted child.
President Donald Trump signed an executive order Thursday to expedite the reclassification of marijuana – an effort to increase research on its medical use but not fully legalize it.
President Donald Trump has signed an executive order to move cannabis from Schedule I to Schedule III under the Controlled ...
Marijuana’s classification as one of the most dangerous and habit-forming substances has long drawn criticism.
A new systematic evidence review finds that cannabis products that carry relatively high levels of the psychoactive compound ...
A new report on HIV in Fiji is recommending the set-up of a needle syringe program, to provide sterile needles, as soon as ...
Phoenix leaders passed a new controversial rule to restrict how volunteers can provide medical treatment and needles to the ...
The move doesn't legalize marijuana, but reclassifying it would allow the FDA to study it for medical purposes.
News-Medical.Net on MSN
THC products provide small improvements in pain but carry side effects
A new systematic evidence review finds that cannabis products that carry relatively high levels of the psychoactive compound tetrahydrocannabinol, commonly known as THC, may provide short-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results